A security holder of Genius Sports (GENI) filed a notice of proposed sale of up to 193,514 common shares, with an aggregate market value of $1,993,232.90. The shares are planned to be sold through Fidelity Brokerage Services LLC on the NYSE around 01/12/2026. These shares were acquired on 01/06/2026 through restricted stock vesting as compensation from the issuer. The filing notes that there were 214,097,454 shares of this class outstanding, giving context for the size of the planned sale.
Nicholas Taylor filed a Rule 144 notice to sell 199,719 shares of GENI common stock. The planned sale is through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $2,084,826.70 based on the figures in the form, and the company had 214,097,454 shares outstanding. The shares being sold were acquired on 01/07/2026 through restricted stock vesting from the issuer as compensation, with payment also dated 01/07/2026.
The form also reports that during the past three months, Nicholas Taylor sold 162,737 common shares for gross proceeds of $1,763,526.91. By signing, the selling holder represents they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
Genius Sports insider Mark A. Locke has filed a notice to sell 53,679 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $556,087.60. The shares are listed on the NYSE, and the approximate sale date indicated is 01/07/2026.
The 53,679 shares to be sold were acquired on 01/06/2026 via restricted stock vesting from the issuer as compensation. The notice also reports prior sales over the past three months, including 131,608 common shares sold on 11/10/2025 and 91,724 common shares sold on 01/06/2026. Shares of the issuer outstanding were reported as 214,097,454.
A holder of GENI common stock has filed a Rule 144 notice to sell 91,724 shares. The proposed sale is through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value listed as 995,132.02. The filing shows 214,097,454 common shares outstanding for the issuer.
The 91,724 shares to be sold were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation, with payment also dated 01/05/2026. The notice also reports that Mark Locke sold 131,608 common shares on 11/10/2025 for gross proceeds of 1,368,736.36 during the prior three months.
Genius Sports (GENI) insider Jack Davison filed a notice of proposed stock sales under Rule 144. The filing covers the planned sale of 177,897 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $1,930,040.13, at a time when 214,097,454 shares were outstanding. These shares were acquired on 01/05/2026 via restricted stock vesting from the issuer as compensation, with the same date listed for payment. The filing also notes prior sales by Davison over the past three months, including 400,673 common shares sold on 11/10/2025 for gross proceeds of $4,167,039.27 and 202,876 common shares sold on 01/05/2026 for gross proceeds of $2,253,729.20.
A holder of GENI common stock filed a notice to sell shares under Rule 144. The filing covers 202,876 common shares, to be sold through Fidelity Brokerage Services LLC, with an aggregate market value of $2,253,729.20. These shares relate to a recent restricted stock vesting on 01/02/2026, received from the issuer as compensation on that date.
The notice identifies the intended trading market as the NYSE, with an approximate sale date of 01/05/2026. It also discloses that the same seller previously sold 400,673 common shares on 11/10/2025, generating $4,167,039.27 in gross proceeds. The filing reports that 214,097,454 common shares were outstanding for the issuer at the time referenced.
A holder of common stock has filed notice of intent to sell 162,737 shares under Rule 144. The shares have an aggregate market value of $1,763,526.91 and are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of December 18, 2025.
All of these shares were acquired from the issuer as restricted stock vesting on multiple dates between January 3, 2023 and January 7, 2025 as compensation. The notice reports that 214,097,454 shares of this class were outstanding, providing context for the overall share count.
GENI shareholder filed a Rule 144 notice for the proposed sale of 9,414 common shares. The shares were acquired on 12/12/2025 through restricted stock vesting as compensation from the issuer and are planned to be sold through Fidelity Brokerage Services LLC on the NYSE around 12/15/2025, with an aggregate market value of $100,750.51. The issuer reported 214,097,454 common shares outstanding, giving context for the size of this planned transaction.
A holder of GENI common stock plans to sell 9,415 shares on the NYSE through Fidelity Brokerage Services LLC. The shares have an aggregate market value of 100,761.21, and shares outstanding are listed as 214,097,454.
These shares were acquired on 12/12/2025 through restricted stock vesting from the issuer as compensation, with payment also dated 12/12/2025. The approximate sale date is 12/15/2025. The person selling represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Genius Sports Limited reported the results of its 2025 Annual General Meeting of Shareholders held on December 10, 2025. A total of 195,422,891 ordinary shares, representing approximately 78.4% of the voting share capital as of November 5, 2025, were present or represented by proxy, indicating strong shareholder participation.
Shareholders approved the 2024 annual report and audited financial statements, with 194,596,645 votes in favor, and re-appointed Kenneth J. Kay and Kimberly Ann Bradley as Class I Directors with support of 98.50% and 99.42% of votes cast, respectively. Daniel Burns was also re-appointed as a Class I Director, but with a closer vote, receiving 57.05% of votes cast in favor and 42.38% against.
WithumSmith+Brown, PC was re-appointed as auditor for SEC filings for the financial year ending December 31, 2025, and BDO LLP was re-appointed for the Guernsey statutory accounts, each with over 99.8% support. Shareholders also passed an ordinary resolution authorising the board to determine the remuneration of each auditor, with 99.77% of votes cast in favor.